The preliminary screening of different adjuvants in transcutaneous immuniza-tion with inactivated human highly pathogenic avian influenza vaccine

SUN Yan-li,SUN Yan-hua,MA An-lun,LU Wen-bao,CHEN Hui-fang,WANG Xi-liang

2009-01-01

Abstract:To screen the potent adjuvants used in transcutaneous immunization with inactivated highly pathogenic avian influenza vaccine,four different adjuvants,CT,CpG ODN1826,CpG ODN2006 and MF59,were used to immunize BALB/c mice together with this kind of vaccine in different proportions by transcutaneous immunization route and sera were collected before the first transcutaneous immunization and every two weeks post immunization.The titers of influenza virus-specific humoral IgG,and IgA were assayed in serum,lung and nasal lavages by ELISA.The titers of hemagglutination inhibition (HAI) and IFN-γand IL-4 produced by splenic lymphocytes were also detected.Our data showed that serum IgG titers and HAI titers in the groups of CpG1826 + HA,CT+HA and CpG1826 + CT+HA were significantly higher than those of HA group(P<0.05),particularly,in CpG1826 + CT+HA group.In addition,the influenza virus-specific IgA and IgG were detected in the lung and nasal lavages.Furthermore,the numbers of splenic lymphocytes producing IFN-γand IL-4 were increased in mice after vaccination with inactivated highly pathogenic avian influenza combined with different adjuvants in comparison with those in control groups.Our result of study indicates that CpG ODN and cholera toxin are potent trancutaneous adjuvants in mouse model inoculated with inactivated high pathogenic avian influenza vaccine,and both of them can induce Th1 and Th2 cytokine production and mucosal immune responses.